Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06557057
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-13
Brief Title:
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study assesses the effect of hormone directed treatment for breast cancer on glucose metabolism
Detailed Description:
PRIMARY OBJECTIVE
I Assess the impact of endocrine adjuvant therapy with aromatase inhibitors in women with hormone receptor positive breast cancer on various indices of glucose homeostasis utilizing oral minimal model assessment in comparison to healthy post menopausal women and another cohort of women on tamoxifen
OUTLINE This is an observational study
Patients undergo blood sample collection glucose testing DEXA scan to measure body composition complete a questionnaire and have their medical records reviewed on study
I Assess the impact of endocrine adjuvant therapy with aromatase inhibitors in women with hormone receptor positive breast cancer on various indices of glucose homeostasis utilizing oral minimal model assessment in comparison to healthy post menopausal women and another cohort of women on tamoxifen
OUTLINE This is an observational study
Patients undergo blood sample collection glucose testing DEXA scan to measure body composition complete a questionnaire and have their medical records reviewed on study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None